Insider Buying Ozan Pamir Acquires Shares of ChromaDex Corp

CDXC Stock  USD 7.72  0.08  1.05%   
About 61% of all Chromadex Corp's shareholders are looking to take a long position. The analysis of overall sentiment of trading Chromadex Corp stock suggests that some investors are interested at this time. The current market sentiment, together with Chromadex Corp's historical and current headlines, can help investors time the market. In addition, many technical investors use Chromadex Corp stock news signals to limit their universe of possible portfolio assets.
  
On November 22, 2024, Ozan Pamir, Chief Financial Officer of ChromaDex Corp, purchased 2,907 shares of the company, according to a SEC Filing. Following this tr

Read at gurufocus.com
Gurufocus Stories at Macroaxis
  

Chromadex Corp Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Chromadex Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Chromadex Corp Fundamental Analysis

We analyze Chromadex Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chromadex Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chromadex Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Book Value Per Share

Book Value Per Share Comparative Analysis

Chromadex Corp is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Chromadex Corp Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Chromadex Corp stock to make a market-neutral strategy. Peer analysis of Chromadex Corp could also be used in its relative valuation, which is a method of valuing Chromadex Corp by comparing valuation metrics with similar companies.

Peers

Chromadex Corp Related Equities

ANTXAN2 Therapeutics   21.90   
0%
100.0%
IPSCCentury Therapeutics   5.52   
0%
25.0%
MNOVMediciNova   2.99   
0%
13.0%
IKNAIkena Oncology   2.37   
0%
10.0%
ADAGAdagene   1.30   
0%
5.0%
RZLTRezolute   1.00   
0%
4.0%
KZRKezar Life   0.95   
0%
4.0%
ACRVAcrivon Therapeutics,   0.80   
0%
3.0%
ANEBAnebulo Pharmaceuticals   0.70   
0%
3.0%
AVTEAerovate Therapeutics   0.38   
1.0%
0%
ELYMEliem Therapeutics   1.30   
5.0%
0%
JANXJanux Therapeutics   2.54   
11.0%
0%
MLYSMineralys Therapeutics,   2.59   
11.0%
0%
NKTXNkarta   4.01   
18.0%
0%
HCWBHCW Biologics   6.00   
27.0%
0%
XCURExicure   7.81   
35.0%
0%

Complementary Tools for Chromadex Stock analysis

When running Chromadex Corp's price analysis, check to measure Chromadex Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chromadex Corp is operating at the current time. Most of Chromadex Corp's value examination focuses on studying past and present price action to predict the probability of Chromadex Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chromadex Corp's price. Additionally, you may evaluate how the addition of Chromadex Corp to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings